|
1
|
Weitz J, Koch M, Debus J, Höhler T, Galle
PR and Büchler MW: Colorectal cancer. Lancet. 365:153–165. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Black RJ, Bray F, Ferlay J and Parkin DM:
Cancer incidence and mortality in the European Union: Cancer
registry data and estimates of national incidence for 1990. Eur J
Cancer. 33:1075–1107. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mundade R, Imperiale TF, Prabhu L, Loehrer
PJ and Lu T: Genetic pathways, prevention, and treatment of
sporadic colorectal cancer. Oncoscience. 1:400–406. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee JH, Cragun D, Thompson Z, Coppola D,
Nicosia SV, Akbari M, Zhang S, McLaughlin J, Narod S, Schildkraut
J, et al: Association between IHC and MSI testing to identify
mismatch repair-deficient patients with ovarian cancer. Genet Test
Mol Biomarkers. 18:229–235. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Haydon AM and Jass JR: Emerging pathways
in colorectal-cancer development. Lancet Oncol. 3:83–88. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jascur T and Boland CR: Structure and
function of the components of the human DNA mismatch repair system.
Int J Cancer. 119:2030–2035. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pawlik TM, Raut CP and Rodriguez-Bigas MA:
Colorectal carcinogenesis: MSI-H versus MSI-L. Dis Markers.
20:199–206. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wheeler JM, Bodmer WF and Mortensen NJ:
DNA mismatch repair genes and colorectal cancer. Gut. 47:148–153.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yoon YS, Yu CS, Kim TW, Kim JH, Jang SJ,
Cho DH, Roh SA and Kim JC: Mismatch repair status in sporadic
colorectal cancer: Immunohistochemistry and microsatellite
instability analyses. J Gastroenterol Hepatol. 26:1733–1739. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lindor NM, Burgart LJ, Leontovich O,
Goldberg RM, Cunningham JM, Sargent DJ, Walsh-Vockley C, Petersen
GM, Walsh MD, Leggett BA, et al: Immunohistochemistry versus
microsatellite instability testing in phenotyping colorectal
tumors. J Clin Oncol. 20:1043–1048. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lanza G, Gafà R, Maestri I, Santini A,
Matteuzzi M and Cavazzini L: Immunohistochemical pattern of
MLH1/MSH2 expression is related to clinical and pathological
features in colorectal adenocarcinomas with microsatellite
instability. Mod Pathol. 15:741–749. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Smith NJ, Bees N, Barbachano Y, Norman AR,
Swift RI and Brown G: Preoperative computed tomography staging of
nonmetastatic colon cancer predicts outcome: Implications for
clinical trials. Br J Cancer. 96:1030–1036. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Boland CR and Goel A: Microsatellite
instability in colorectal cancer. Gastroenterology. 138:2073–2087.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Iacopetta B, Grieu F and Amanuel B:
Microsatellite instability in colorectal cancer. Asia Pac J Clin
Oncol. 6:260–269. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sameer AS, Nissar S and Fatima K: Mismatch
repair pathway: Molecules, functions, and role in colorectal
carcinogenesis. Eur J Cancer Prev. 23:246–257. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Michailidi C, Papavassiliou AG and
Troungos C: DNA repair mechanisms in colorectal carcinogenesis.
Curr Mol Med. 12:237–246. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Raut CP, Pawlik TM and Rodriguez-Bigas MA:
Clinicopathologic features in colorectal cancer patients with
microsatellite instability. Mutat Res. 568:275–282. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Boland CR, Thibodeau SN, Hamilton SR,
Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA,
Fodde R, Ranzani GN and Srivastava S: A National cancer institute
workshop on microsatellite instability for cancer detection and
familial predisposition: Development of international criteria for
the determination of microsatellite instability in colorectal
cancer. Cancer Res. 58:5248–5257. 1998.PubMed/NCBI
|
|
19
|
Bao F, Panarelli NC, Rennert H, Sherr DL
and Yantiss RK: Neoadjuvant therapy induces loss of MSH6 expression
in colorectal carcinoma. Am J Surg Pathol. 34:1798–1804. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim JC, Cho YK, Roh SA, Yu CS, Gong G,
Jang SJ, Kim SY and Kim YS: Individual tumorigenesis pathways of
sporadic colorectal adenocarcinomas are associated with the
biological behavior of tumors. Cancer Sci. 99:1348–1354. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sinicrope F, Foster NR, Sargent DJ,
Thibodeau SN, Smyrk TC and O'Connell MJ: North Central Cancer
Treatment Group: Model-based prediction of defective DNA mismatch
repair using clinicopathological variables in sporadic colon cancer
patients. Cancer. 116:1691–1698. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jover R, Zapater P, Castells A, Llor X,
Andreu M, Cubiella J, Balaguer F, Sempere L, Xicola RM, Bujanda L,
et al: The efficacy of adjuvant chemotherapy with 5-fluorouracil in
colorectal cancer depends on the mismatch repair status. Eur J
Cancer. 45:365–373. 2009. View Article : Google Scholar : PubMed/NCBI
|
